Merck is eyeing new immunology deals, chief medical officer says: #JPM24

Lei Lei Wu

News Reporter

Merck wants to beef up its immunology pipeline through additional deals, the Big Pharma’s chief medical officer Eliav Barr said at an Endpoints News event …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Merck is eyeing new immunology deals, chief medical officer says: #JPM24

Lei Lei Wu

News Reporter

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Mer­ck is eye­ing new im­munol­o­gy deals, chief med­ical of­fi­cer says: #JPM24

News Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Merck is eyeing new immunology deals, chief medical officer says: #JPM24